Vistagen Therapeutics Inc. (VTGN) has disclosed a new risk, in the Accounting & Financial Operations category.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The analyst notes that investing in Vistagen Therapeutics Inc.’s securities entails a high degree of risk, as multiple identified and unidentified uncertainties could materially damage its business, reputation, financial condition, and future prospects. Such developments could drive a significant decline in the company’s common stock price, potentially resulting in partial or total loss of investor capital.
Overall, Wall Street has a Hold consensus rating on VTGN stock based on 5 Holds.
To learn more about Vistagen Therapeutics Inc.’s risk factors, click here.